Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Major reduction of NKT cells in patients with severe COVID-19 pneumonia.
Zingaropoli MA, Perri V, Pasculli P, Cogliati Dezza F, Nijhawan P, Savelloni G, La Torre G, D'Agostino C, Mengoni F, Lichtner M, Ciardi MR, Mastroianni CM. Zingaropoli MA, et al. Among authors: perri v. Clin Immunol. 2021 Jan;222:108630. doi: 10.1016/j.clim.2020.108630. Epub 2020 Nov 13. Clin Immunol. 2021. PMID: 33189887 Free PMC article.
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M. Zingaropoli MA, et al. Among authors: perri v. Front Immunol. 2021 Feb 26;12:627548. doi: 10.3389/fimmu.2021.627548. eCollection 2021. Front Immunol. 2021. PMID: 33777012 Free PMC article.
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
Violi F, Ceccarelli G, Cangemi R, Cipollone F, D'Ardes D, Oliva A, Pirro M, Rocco M, Alessandri F, D'Ettorre G, Lichtner M, Pignatelli P, Ferro D, Ruberto F, Lip GYH, Pugliese F, Mastroianni CM; Intensive Care, Infectious Diseases COVID-19 Study Group of Sapienza University. Violi F, et al. Intern Emerg Med. 2021 Aug;16(5):1231-1237. doi: 10.1007/s11739-020-02621-8. Epub 2021 Jul 4. Intern Emerg Med. 2021. PMID: 34218413 Free PMC article.
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study.
Russo G, Solimini A, Zuccalà P, Zingaropoli MA, Carraro A, Pasculli P, Perri V, Marocco R, Kertusha B, Del Borgo C, Del Giudice E, Fondaco L, Tieghi T, D'Agostino C, Oliva A, Vullo V, Ciardi MR, Mastroianni CM, Lichtner M. Russo G, et al. Among authors: perri v. PLoS One. 2021 Sep 10;16(9):e0257376. doi: 10.1371/journal.pone.0257376. eCollection 2021. PLoS One. 2021. PMID: 34506608 Free PMC article.
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.
Fedele G, Russo G, Schiavoni I, Leone P, Olivetta E, Perri V, Zingaropoli MA, Ciardi MR, Pasculli P, Mastroianni CM, Stefanelli P. Fedele G, et al. Among authors: perri v. Diagn Microbiol Infect Dis. 2021 Sep 12;105(1):115539. doi: 10.1016/j.diagmicrobio.2021.115539. Online ahead of print. Diagn Microbiol Infect Dis. 2021. PMID: 34624706 Free PMC article.
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study.
Zingaropoli MA, Pasculli P, Iannetta M, Perri V, Tartaglia M, Crisafulli SG, Merluzzo C, Baione V, Mazzochi L, Taglietti A, Pauri F, Frontoni M, Altieri M, Gaeta A, Antonelli G, Conte A, Mastroianni CM, Ciardi MR. Zingaropoli MA, et al. Among authors: perri v. Mult Scler J Exp Transl Clin. 2022 Jan 4;8(1):20552173211065731. doi: 10.1177/20552173211065731. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35003758 Free PMC article.
206 results